2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary
anticoagulants
Certification
Cardiology
Coronary Artery Disease
Risk Assessment
03 medical and health sciences
0302 clinical medicine
Risk Factors
coronary artery revascularization interventions: stents
myocardial revasularization
Humans
acute coronary syndromes
Angioplasty, Balloon, Coronary
Quality of Health Care
ACCF/AHA Practice Guidelines
heart diseases
Evidence-Based Medicine
ultrasound
Patient Selection
American Heart Association
arrhythmias, cardiac
United States
drug therapy
3. Good health
Treatment Outcome
Practice Guidelines as Topic
Clinical Competence
antiplatelet agents
coronary angiography
platelet aggregation inhibitor
Platelet Aggregation Inhibitors
DOI:
10.1161/cir.0b013e31823a5596
Publication Date:
2011-11-08T08:48:14Z
AUTHORS (19)
ABSTRACT
Alice K. Jacobs, MD, FACC, FAHA, Chair Jeffrey L. Anderson, MD, FACC, FAHA, Chair-Elect Nancy Albert, PhD, CCNS, CCRN, FAHA Mark A. Creager, MD, FACC, FAHA Steven M. Ettinger, MD, FACC Robert A. Guyton, MD, FACC Jonathan L. Halperin, MD, FACC, FAHA Judith S. Hochman, MD, FACC, FAHA
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (445)
CITATIONS (439)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....